These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome. Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999 [TBL] [Abstract][Full Text] [Related]
4. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children. Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365 [TBL] [Abstract][Full Text] [Related]
5. Composition and function of pulmonary surfactant in adult respiratory distress syndrome. Hallman M; Maasilta P; Sipilä I; Tahvanainen J Eur Respir J Suppl; 1989 Mar; 3():104s-108s. PubMed ID: 2662993 [TBL] [Abstract][Full Text] [Related]
6. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632 [TBL] [Abstract][Full Text] [Related]
7. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298 [TBL] [Abstract][Full Text] [Related]
8. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. Bernhard W; Haagsman HP; Tschernig T; Poets CF; Postle AD; van Eijk ME; von der Hardt H Am J Respir Cell Mol Biol; 1997 Jul; 17(1):41-50. PubMed ID: 9224208 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Veldhuizen RA; McCaig LA; Akino T; Lewis JF Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1867-71. PubMed ID: 8520748 [TBL] [Abstract][Full Text] [Related]
10. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties. Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha alters phospholipid content in the bronchoalveolar lavage-accessible space of isolated perfused rat lungs. Hertzog JH; Godinez MH; Godinez RI Crit Care Med; 1994 Dec; 22(12):1969-75. PubMed ID: 7988135 [TBL] [Abstract][Full Text] [Related]
12. An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. Schmidt R; Steinhilber W; Ruppert C; Daum C; Grimminger F; Seeger W; Günther A Am J Respir Crit Care Med; 2002 Feb; 165(4):470-4. PubMed ID: 11850338 [TBL] [Abstract][Full Text] [Related]
13. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies. Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845 [TBL] [Abstract][Full Text] [Related]
14. Contrast media inhibit exogenous surfactant therapy in rats with acute respiratory distress syndrome. Kesecioglu J; Haitsma JJ; Schultz MJ; den Heeten GJ; Lachmann B Clin Physiol Funct Imaging; 2006 Mar; 26(2):120-6. PubMed ID: 16494603 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Wittkowski H; Sturrock A; van Zoelen MA; Viemann D; van der Poll T; Hoidal JR; Roth J; Foell D Crit Care Med; 2007 May; 35(5):1369-75. PubMed ID: 17414728 [TBL] [Abstract][Full Text] [Related]
16. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Pison U; Seeger W; Buchhorn R; Joka T; Brand M; Obertacke U; Neuhof H; Schmit-Neuerburg KP Am Rev Respir Dis; 1989 Oct; 140(4):1033-9. PubMed ID: 2802366 [TBL] [Abstract][Full Text] [Related]
17. Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome. Danlois F; Zaltash S; Johansson J; Robertson B; Haagsman HP; van Eijk M; Beers MF; Rollin F; Ruysschaert JM; Vandenbussche G Biochem J; 2000 Nov; 351 Pt 3(Pt 3):779-87. PubMed ID: 11042134 [TBL] [Abstract][Full Text] [Related]
18. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595 [TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor expression is suppressed in early acute lung injury/acute respiratory distress syndrome by smad and c-Abl pathways. Chandel NS; Budinger GR; Mutlu GM; Varga J; Synenki L; Donnelly HK; Zirk A; Eisenbart J; Jovanovic B; Jain M Crit Care Med; 2009 May; 37(5):1678-84. PubMed ID: 19325470 [TBL] [Abstract][Full Text] [Related]
20. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. McCormack FX; King TE; Bucher BL; Nielsen L; Mason RJ Am J Respir Crit Care Med; 1995 Aug; 152(2):751-9. PubMed ID: 7633738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]